Novel Compounds in the Treatment of the CNS Disorders
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (15 May 2022) | Viewed by 44773
Special Issue Editors
Interests: depression; anxiety; preclinical study; neuropharmacology; neuropsychopharmacology; toxicological and biochemical analysis
Special Issues, Collections and Topics in MDPI journals
Interests: depression; anxiety; epilepsy; neuroscience; preclinical studies
Special Issues, Collections and Topics in MDPI journals
Interests: depression; anxiety; epilepsy; neuroscience; preclinical studies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Central nervous system (CNS) disorders are a broad group of neurological conditions affecting the functioning of the brain or spinal cord and in consequence, deteriorating quality of life of a given patient. Amongst them, bipolar disorder, depression, epilepsy/seizures, migraine, Parkinson's disease, Alzheimer's disease, Huntington's disease, attention deficit/hyperactivity disorder, and multiple sclerosis are most frequently diagnosed. These neurological conditions can be caused by several different factors, such as stroke, trauma, infections, autoimmune disorders, tumors, brain or spinal cord degeneration, structural defects or genetic determinants. Despite enormous progress in medicine and pharmacotherapy, management of the CNS diseases is still challenging: most of these disorders cannot be thoroughly cured, not all patients achieve even a partial remission, prescribed drugs induce troublesome side effects. Therefore, continuous attempts have been made to develop new treatment strategies and safer more effective drugs. Research and medical teams focus on diverse treatment options: innovative compounds, combinations of well-known substances and surgical and neurorehabilitation procedures. In our Special Issue on Novel Compounds in the Treatment of the CNS Disorders, we aim to bring together experts working in the field of neurological conditions and invite them to present their recent results from both pre-clinical and clinical studies related to pharmacotherapy of CNS disorders. Review articles and short communications on the latest achievements in the management of CNS disorders are also welcome.
Prof. Dr. Ewa Poleszak
Dr. Anna Serefko
Dr. Aleksandra Szopa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ADHD
- autism
- depression
- epilepsy
- neurodegenerative diseases
- neuroscience
- preclinical studies
- clinical studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.